| Molly Ann Williams, MA CF-SLP | |
|
11160 Huron St Ste 200, Northglenn, CO 80234-3335 | |
| (720) 872-6472 | |
| Not Available |
| Full Name | Molly Ann Williams |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 11160 Huron St Ste 200, Northglenn, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578131843 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | PSLP.0000802 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Molly Ann Williams, MA CF-SLP 12490 Albion St, Thornton, CO 80241-2933 Ph: (575) 496-7371 | Molly Ann Williams, MA CF-SLP 11160 Huron St Ste 200, Northglenn, CO 80234-3335 Ph: (720) 872-6472 |
News Archive
A recent study by Vanderbilt researchers of 11 counties in Middle Tennessee revealed that children with autism spectrum disorder were nearly 2.5 times more likely than children without ASD to be reported to the Child Abuse Hotline by the age of 8.
An article in the July/August issue of the Archives of Facial Plastic Surgery reports that the use of Radiance FN/Radiesse injectable implant material appears effective and well tolerated by patients undergoing facial soft tissue augmentation, and patient satisfaction with treatment is high.
A study using functional magnetic resonance imaging (fMRI) shows that expert advice may shut down areas of the brain responsible for decision-making processes, particularly when individuals are trying to evaluate a situation where risk is involved.
More than 4 million people living with HIV in low- and middle-income countries had access to life-saving antiretroviral therapy (ART) by the end of 2008, according to a report released Wednesday by the WHO, UNICEF and UNAIDS, the Associated Press reports.
After phase 1 results of Seattle Children's Pediatric Leukemia Adoptive Therapy trial have shown T-cell immunotherapy to be effective in getting 93 percent of patients with relapsed or refractory acute lymphoblastic leukemia into complete initial remission, researchers have now opened a first-in-human clinical trial aimed at reducing the rate of relapse after the therapy, which is about 50 percent.
› Verified 1 days ago
Kelsey Mcquown, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 601 W 100th Pl, Northglenn, CO 80260 Phone: 720-972-2741 | |
Abbey Wicklund, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11160 Huron St, Northglenn, CO 80234 Phone: 720-872-6472 | |
Jennifer Rae Rael, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9580 Damon Dr, Northglenn, CO 80260 Phone: 720-972-3574 | |
Bryn Anne Medley, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11154 Huron St Ste 100, Northglenn, CO 80234 Phone: 720-457-5956 | |
Rachel Feierman, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11160 Huron St Ste 200, Northglenn, CO 80234 Phone: 647-272-0872 | |
Lena Santacaterina, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11630 Community Center Dr Apt 62, Northglenn, CO 80233 Phone: 561-876-2047 | |
Corinne Beabeth Stevens, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11154 Huron St Ste 101, Northglenn, CO 80234 Phone: 303-659-4090 |